Heart failure (HF) is one of the leading causes of death, hospitalization, and rehospitalization worldwide. In spite of advances in treatment with new medications, devices, and heart transplantation, the condition is still associated with significant morbidity and mortality.1 One factor that likely contributes to this fact is the difficulty in titrating doses of drugs targeted at treating HF.2 […]